The gross proceeds from the offering, before deducting underwriting fees and other offering expenses payable by the Company, are expected to be $6.2 million. The offering is expected to close on or ...
Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the pricing of its initial public offering of 1,500,000 ...